Suppr超能文献

二十五年的验证性适应性设计:机遇与陷阱。

Twenty-five years of confirmatory adaptive designs: opportunities and pitfalls.

作者信息

Bauer Peter, Bretz Frank, Dragalin Vladimir, König Franz, Wassmer Gernot

机构信息

Section of Medical Statistics, Medical University of Vienna, Spitalgasse 23, 1090 Wien, Austria.

Novartis Pharma AG, Lichtstrasse 35, 4002, Basel, Switzerland.

出版信息

Stat Med. 2016 Feb 10;35(3):325-47. doi: 10.1002/sim.6472. Epub 2015 Mar 16.

Abstract

'Multistage testing with adaptive designs' was the title of an article by Peter Bauer that appeared 1989 in the German journal Biometrie und Informatik in Medizin und Biologie. The journal does not exist anymore but the methodology found widespread interest in the scientific community over the past 25 years. The use of such multistage adaptive designs raised many controversial discussions from the beginning on, especially after the publication by Bauer and Köhne 1994 in Biometrics: Broad enthusiasm about potential applications of such designs faced critical positions regarding their statistical efficiency. Despite, or possibly because of, this controversy, the methodology and its areas of applications grew steadily over the years, with significant contributions from statisticians working in academia, industry and agencies around the world. In the meantime, such type of adaptive designs have become the subject of two major regulatory guidance documents in the US and Europe and the field is still evolving. Developments are particularly noteworthy in the most important applications of adaptive designs, including sample size reassessment, treatment selection procedures, and population enrichment designs. In this article, we summarize the developments over the past 25 years from different perspectives. We provide a historical overview of the early days, review the key methodological concepts and summarize regulatory and industry perspectives on such designs. Then, we illustrate the application of adaptive designs with three case studies, including unblinded sample size reassessment, adaptive treatment selection, and adaptive endpoint selection. We also discuss the availability of software for evaluating and performing such designs. We conclude with a critical review of how expectations from the beginning were fulfilled, and - if not - discuss potential reasons why this did not happen.

摘要

彼得·鲍尔于1989年发表在德国期刊《医学与生物学中的生物统计学与信息学》上的一篇文章标题为“采用适应性设计的多阶段试验”。该期刊现已停刊,但在过去25年里,这种方法在科学界引起了广泛关注。从一开始,这种多阶段适应性设计的使用就引发了许多有争议的讨论,尤其是在鲍尔和克内于1994年在《生物统计学》上发表文章之后:对这类设计潜在应用的广泛热情,面临着对其统计效率的批评立场。尽管或者可能正是因为这种争议,这些年来该方法及其应用领域稳步发展,世界各地学术界、行业和机构的统计学家都做出了重要贡献。与此同时,这类适应性设计已成为美国和欧洲两份主要监管指南文件的主题,该领域仍在不断发展。在适应性设计的最重要应用方面,包括样本量重新评估、治疗选择程序和人群富集设计,进展尤其值得注意。在本文中,我们从不同角度总结了过去25年的发展情况。我们提供了早期的历史概述,回顾了关键的方法学概念,并总结了对此类设计的监管和行业观点。然后,我们通过三个案例研究来说明适应性设计的应用,包括非盲法样本量重新评估、适应性治疗选择和适应性终点选择。我们还讨论了用于评估和执行此类设计的软件的可用性。我们最后对最初的期望是否得到满足进行了批判性回顾,如果没有,讨论了未能实现的潜在原因。

相似文献

1
Twenty-five years of confirmatory adaptive designs: opportunities and pitfalls.
Stat Med. 2016 Feb 10;35(3):325-47. doi: 10.1002/sim.6472. Epub 2015 Mar 16.
4
On sample size determination in multi-armed confirmatory adaptive designs.
J Biopharm Stat. 2011 Jul;21(4):802-17. doi: 10.1080/10543406.2011.551336.
5
Nested combination tests with a time-to-event endpoint using a short-term endpoint for design adaptations.
Pharm Stat. 2019 May;18(3):329-350. doi: 10.1002/pst.1926. Epub 2019 Jan 16.
7
Understanding the FDA guidance on adaptive designs: historical, legal, and statistical perspectives.
J Biopharm Stat. 2010 Nov;20(6):1178-219. doi: 10.1080/10543406.2010.514462.
8
Adaptive designs with correlated test statistics.
Stat Med. 2009 May 1;28(10):1429-44. doi: 10.1002/sim.3555.
9
Adaptive methods: telling "the rest of the story".
J Biopharm Stat. 2010 Nov;20(6):1150-65. doi: 10.1080/10543406.2010.514457.

引用本文的文献

1
Confidence Intervals for Adaptive Trial Designs II: Case Study and Practical Guidance.
Stat Med. 2025 Aug;44(18-19):e70202. doi: 10.1002/sim.70202.
2
Randomization in clinical trials with small sample sizes using group sequential designs.
PLoS One. 2025 Jun 13;20(6):e0325333. doi: 10.1371/journal.pone.0325333. eCollection 2025.
3
Closed MCP-Mod for Pairwise Comparisons of Several Doses With a Control.
Stat Med. 2025 May;44(10-12):e70124. doi: 10.1002/sim.70124.
4
Use of Bayesian approaches in oncology clinical trials: A cross-sectional analysis.
Front Pharmacol. 2025 Mar 25;16:1548997. doi: 10.3389/fphar.2025.1548997. eCollection 2025.
5
Adaptive Weight Selection for Time-To-Event Data Under Non-Proportional Hazards.
Stat Med. 2025 Mar 15;44(6):e70045. doi: 10.1002/sim.70045.
6
Targeting the SARS-CoV-2 reservoir in long COVID.
Lancet Infect Dis. 2025 May;25(5):e294-e306. doi: 10.1016/S1473-3099(24)00769-2. Epub 2025 Feb 10.
8
New results on optimal conditional error functions for adaptive two-stage designs.
J Appl Stat. 2024 Apr 17;51(15):3178-3194. doi: 10.1080/02664763.2024.2342424. eCollection 2024.
9
The impact of heterogeneity on the analysis of platform trials with normally distributed outcomes.
BMC Med Res Methodol. 2024 Jul 30;24(1):163. doi: 10.1186/s12874-024-02293-4.
10
Use of Seamless Study Designs in Oncology Clinical Development- A Survey Conducted by IDSWG Oncology Sub-team.
Ther Innov Regul Sci. 2024 Sep;58(5):978-986. doi: 10.1007/s43441-024-00676-9. Epub 2024 Jun 22.

本文引用的文献

1
Adaptive Design: Results of 2012 Survey on Perception and Use.
Ther Innov Regul Sci. 2014 Jul;48(4):473-481. doi: 10.1177/2168479014522468.
2
Views on Emerging Issues Pertaining to Data Monitoring Committees for Adaptive Trials.
Ther Innov Regul Sci. 2013 Jul;47(4):495-502. doi: 10.1177/2168479013486996.
3
Simultaneous confidence intervals that are compatible with closed testing in adaptive designs.
Biometrika. 2013 Dec 1;100(4):985-996. doi: 10.1093/biomet/ast035.
4
A randomized, controlled trial of oral propranolol in infantile hemangioma.
N Engl J Med. 2015 Feb 19;372(8):735-46. doi: 10.1056/NEJMoa1404710.
5
Adaptive seamless designs with interim treatment selection: a case study in oncology.
Stat Med. 2015 Apr 15;34(8):1317-33. doi: 10.1002/sim.6407. Epub 2015 Jan 7.
6
Adaptive designs for subpopulation analysis optimizing utility functions.
Biom J. 2015 Jan;57(1):76-89. doi: 10.1002/bimj.201300257. Epub 2014 Nov 14.
7
A simple and flexible graphical approach for adaptive group-sequential clinical trials.
J Biopharm Stat. 2016;26(2):202-16. doi: 10.1080/10543406.2014.972509. Epub 2014 Nov 5.
8
Adaptive graph-based multiple testing procedures.
Pharm Stat. 2014 Nov-Dec;13(6):345-56. doi: 10.1002/pst.1640. Epub 2014 Oct 16.
10
Connections between permutation and t-tests: relevance to adaptive methods.
Stat Med. 2014 Nov 30;33(27):4734-42. doi: 10.1002/sim.6288. Epub 2014 Aug 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验